Description: Learn about SKYRIZI® for adults with moderate to severe Crohn’s disease. See full Safety and Prescribing Information.
Learn how AbbVie could help you save on SKYRIZI. Call 1.866.SKYRIZI or click tap to learn more ▸
IL-23 inhibitor (IL-23i) with clinical remission and endoscopic response co-primary measures in label at both 12 and 52 weeks.
Learn how SKYRIZI helps people with Crohn's achieve symptom relief, long-lasting remission at 1 year , and endoscopic improvement .